Relief Therapeutics Holding AG (RLFTF)

[mc67]

$RLFTF Sounds like the FDA are liking the results and don't want to leave current lives at risk out..

"The FDA also granted an expanded access protocol for RLF-100 (aviptadil), from Geneva-based Relief Therapeutics Holdings AG and Radnor, Pa.-based Neurorx Inc., to those patients who are ineligible for enrollment in clinical trials" -

From the Article in Bio-World